Clinical Trial Update: Methylene Blue Mouthwash for the Treatment of Oral Mucositis Pain in Patients With Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating methylene blue mouthwash for treating oral mucositis pain in cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Mucositis

Drugs mentioned

• Methylene blue mouthwash (Methylene blue)

Snippet

Sponsor: Mayo Clinic | Conditions: Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm | Phase 3 | Status: COMPLETED